Luna Bioscience moves ahead with work on a vaccine to prevent a deadly infection that spreads from animals to humans, as ...
Chief Executive Tom Polen said he believes the separation would help differentiate BD in the medical-technology industry, and ...
We recently compiled a list of the Cathie Wood’s Stock Portfolio: 2025 Stock Picks. In this article, we are going to take a ...
BlueArc Biosciences has been a winner in all three phases so far of the LymeX Innovation Accelerator competition as it works ...
LUND, SE / ACCESS Newswire / February 6, 2025 / Alligator Bioscience (STO:ATORX) FDA feedback validates the clinical ...
Twist Bioscience Corporation (NASDAQ: TWST), a core mid-cap growth and value equity company in the life sciences segment of ...
Research analysts at William Blair issued their Q2 2026 earnings per share (EPS) estimates for Twist Bioscience in a report ...
Avanzanite Bioscience B.V., a pioneering commercial-stage specialty pharmaceutical company advancing life-changing medicines ...
Skye Bioscience, Inc.’s SKYE share price has surged by 27.04%, which has investors questioning if this is right time to sell.
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Skye Bioscience (SKYE – Research Report), Eton ...
Learn more about whether Twist Bioscience Corporation or Veracyte, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.
SOUTH SAN FRANCISCO, Calif. (AP) — Twist Bioscience Corp. (TWST) on Monday reported a loss of $31.6 million in its fiscal first quarter. The South San ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback